Almonty Industries Inc Common Shares (ALM) had the highest return between June 1, 2017 and September 18, 2017 by a mid-cap US stock, returning 166.5%.
| ASSET | DATE | % RETURN |
|---|---|---|
Almonty Industries Inc Common Shares (ALM) | 6/1/2017 - 9/18/2017 | 166.51% |
Skyline (SKY) | 6/1/2017 - 9/18/2017 | 131.01% |
Arrowhead Pharmaceuticals (ARWR) | 6/1/2017 - 9/18/2017 | 125.17% |
Enphase Energy (ENPH) | 6/1/2017 - 9/18/2017 | 98.68% |
Calumet Specialty Products Partners (CLMT) | 6/1/2017 - 9/18/2017 | 93.67% |
Amicus Therapeutics (FOLD) | 6/1/2017 - 9/18/2017 | 70.24% |
TAL Education (TAL) | 6/1/2017 - 9/18/2017 | 69.08% |
Immunitybio (IBRX) | 6/1/2017 - 9/18/2017 | 63.01% |
Corcept Therapeutics (CORT) | 6/1/2017 - 9/18/2017 | 62.81% |
PTC Therapeutics (PTCT) | 6/1/2017 - 9/18/2017 | 62.37% |
AeroVironment (AVAV) | 6/1/2017 - 9/18/2017 | 57.87% |
Appfolio (APPF) | 6/1/2017 - 9/18/2017 | 57.27% |
Sarepta Therapeutics (SRPT) | 6/1/2017 - 9/18/2017 | 56.83% |
Autohome (ATHM) | 6/1/2017 - 9/18/2017 | 56.3% |
ArcBest (ARCB) | 6/1/2017 - 9/18/2017 | 54.07% |
RadNet (RDNT) | 6/1/2017 - 9/18/2017 | 53.1% |
Hudbay Minerals (HBM) | 6/1/2017 - 9/18/2017 | 49.15% |
Option Care Health (OPCH) | 6/1/2017 - 9/18/2017 | 48.62% |
Celsius (CELH) | 6/1/2017 - 9/18/2017 | 46.5% |
Travere Therapeutics (TVTX) | 6/1/2017 - 9/18/2017 | 45.48% |
SolarEdge Technologies (SEDG) | 6/1/2017 - 9/18/2017 | 45.26% |
Protagonist Therapeutics (PTGX) | 6/1/2017 - 9/18/2017 | 44.96% |
Warrior Met Coal (HCC) | 6/1/2017 - 9/18/2017 | 44.62% |
Skeena Resources (SKE) | 6/1/2017 - 9/18/2017 | 43.85% |
Constellium (CSTM) | 6/1/2017 - 9/18/2017 | 43.28% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
